References
- Aybek, H., et al., 2006. Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. International journal of urology, 13, 1380–1384.
- Bartoli, F., et al., 2011. Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. Journal of pediatric surgery, 46, 530–536.
- Castagnetti, M., et al., 2008. Scintigraphic renal function after unilateral pyeloplasty in children: a systematic review. BJU international, 102, 862–868.
- Caubet, C., et al., 2010. Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatric nephrology, 25, 27–35.
- Chertin, B., et al., 2002. Does delaying pyeloplasty affect renal function in children with a prenatal diagnosis of pelvi-ureteric junction obstruction? *BJU international, 90, 72–75.
- Chevalier, R.L., 2004. Biomarkers of congenital obstructive nephropathy: past, present and future. Journal of urology, 172, 852–857.
- Cost, N.G., et al., 2013. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. Journal of urology, 190, 1462–1467.
- Decramer, S., Bascands, J.L., and Schanstra, J.P., 2007. Non-invasive markers of ureteropelvic junction obstruction. World journal of urology, 25, 457–465.
- El-Sherbiny, M.T., et al., 2002. Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. Journal of urology, 168, 1798–1800.
- Endre, Z.H. and Westhuyzen, J., 2008. Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton), 13, 91–98.
- Grandaliano, G., et al., 2000. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney international, 58, 182–192.
- Kajbafzadeh, A.M., et al., 2010. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. Journal of urology, 183, 2353–2360.
- Kausik, S. and Segura, J.W., 2003. Surgical management of ureteropelvic junction obstruction in adults. International Brazilian journal of urology, 29, 3–10.
- Khan, F., et al., 2014. Management of ureteropelvic junction obstruction in adults. Nature reviews urology, 11, 629–638.
- Lam, J.S., Breda, A., and Schulam, P.G., 2007. Ureteropelvic junction obstruction. Journal of urology, 177, 1652–1658.
- Lam, W., et al., 2015. Is routine postoperative diuresis renography indicated in all adult patients after pyeloplasty for ureteropelvic junction obstruction? Urology, 85, 246–251.
- Lucarelli, G., et al., 2014. Emerging urinary markers of renal injury in obstructive nephropathy. BioMed research international, 2014, 303298.
- Madsen, M.G., et al., 2011. Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. Journal of pediatric urology, 7, 105–112.
- Madsen, M.G., et al., 2012a. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. Journal of pediatric urology, 9, 838–845
- Madsen, M.G., et al., 2012b. Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children. Pediatric nephrology, 27, 2099–2106.
- Mesrobian, H.G.O. and Mirza, S.P., 2012. Hydronephrosis: a view from the inside. Pediatric clinics of North America, 59, 839–851.
- Papachristou, F., Pavlaki, A., and Printza, N., 2014. Urinary and serum biomarkers in ureteropelvic junction obstruction: a systematic review. Biomarkers, 19, 531–540.
- Park, J.M. and Bloom, D.A., 1998. The pathophysiology of UPJ obstruction. Current concepts. The urologic clinics of North America, 25, 161–169.
- Taha, M.A., et al., 2007a. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Urology, 69, 560–564. discussion 564-565.
- Taha, M.A., et al., 2007b. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: role of urinary tubular enzymes. Journal of urology, 178, 640–646.
- Taha, M.A., et al., 2007c. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. BJU international, 99, 899–903.
- Tapia, J. and Gonzalez, R., 1995. Pyeloplasty improves renal function and somatic growth in children with ureteropelvic junction obstruction. Journal of urology, 154, 218–222.
- Wasilewska, A., et al., 2011. KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatric nephrology, 26, 579–586.